Was just reading up on another company in the space, trying to get some idea on where this may settle out, decent presentation linked below from US listed Axogen, they are many miles further down the road but are valued around $1b US after shedding over 50% of their value. Some very relevant information in their presentation.
https://d1io3yog0oux5.cloudfront.ne...-Year Axogen_Corporate_Presentation Final.pdf
Ann: First Patients Complete Nerve Regeneration Trial, page-184
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.5¢ | $49.66K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20305 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 77938 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |